High materiality7/10
Roivant Sciences price target raised to $47 from $41 at H.C. Wainwright
Why it may matterVerify against the original reporting
Upside potential remains as target exceeds current price.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Target raised to $47; current price $42.03.
- ROIV PT raised to $47; price $42.03
Key facts
- 01
Target: $47
- 02
Posted price: $42.03
- 03
Analyst firm: H.C. Wainwright
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.